Tsc1 Regulates the Proliferation Capacity of Bone-Marrow Derived Mesenchymal Stem Cells
Open Access
Abstract
TSC1 is a tumor suppressor that inhibits cell growth via negative regulation of the mammalian target of rapamycin complex (mTORC1). TSC1 mutations are associated with Tuberous Sclerosis Complex (TSC), characterized by multiple benign tumors of mesenchymal and epithelial origin. TSC1 modulates self-renewal and differentiation in hematopoietic stem cells; however, its effects on mesenchymal stem cells (MSCs) are unknown. We investigated the impact of Tsc1 inactivation in murine bone marrow (BM)-MSCs, using tissue-specific, transgelin (Tagln)-mediated cre-recombination, targeting both BM-MSCs and smooth muscle cells. Tsc1 mutants were viable, but homozygous inactivation led to a dwarfed appearance with TSC-like pathologies in multiple organs and reduced survival. In young (28 day old) mice, Tsc1 deficiency-induced significant cell expansion of non-hematopoietic BM in vivo, and MSC colony-forming potential in vitro, that was normalized upon treatment with the mTOR inhibitor, everolimus. The hyperproliferative BM-MSC phenotype was lost in aged (1.5 yr) mice, and Tsc1 inactivation was also accompanied by elevated ROS and increased senescence. ShRNA-mediated knockdown of Tsc1 in BM-MSCs replicated the hyperproliferative BM-MSC phenotype and led to impaired adipogenic and myogenic differentiation. Our data show that Tsc1 is a negative regulator of BM-MSC proliferation and support a pivotal role for the Tsc1-mTOR axis in the maintenance of the mesenchymal progenitor pool.Keywords
Funding Information
- American Cancer Society (RSG-08-161-DDC)
This publication has 60 references indexed in Scilit:
- The elusive nature and function of mesenchymal stem cellsNature Reviews Molecular Cell Biology, 2011
- Smooth muscle protein-22-mediated deletion of Tsc1 results in cardiac hypertrophy that is mTORC1-mediated and reversed by rapamycinHuman Molecular Genetics, 2011
- mTOR Mediates Wnt-Induced Epidermal Stem Cell Exhaustion and AgingCell Stem Cell, 2009
- Rapamycin fed late in life extends lifespan in genetically heterogeneous miceNature, 2009
- A novel signaling network as a critical rheostat for the biology and maintenance of the normal stem cell and the cancer-initiating cellCurrent Opinion in Genetics & Development, 2009
- mTORC1-dependent and -independent regulation of stem cell renewal, differentiation, and mobilizationProceedings of the National Academy of Sciences, 2008
- TSC–mTOR maintains quiescence and function of hematopoietic stem cells by repressing mitochondrial biogenesis and reactive oxygen speciesJournal of Experimental Medicine, 2008
- The TSC1–TSC2 complex: a molecular switchboard controlling cell growthBiochemical Journal, 2008
- Constitutive mTOR activation in TSC mutants sensitizes cells to energy starvation and genomic damage via p53The EMBO Journal, 2007
- Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statementCytotherapy, 2006